Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00381056 · ClinicalTrials.gov registry record · NA
The Labor and Delivery Teamwork Intervention Trial
A NA study of Adverse Maternal and Neonatal Outcomes, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 30,000
- Enrollment target
- 15
- Study locations
NCT00381056: Completed NA study of Adverse Maternal and Neonatal Outcomes, sponsored by Beth Israel Deaconess Medical Center.
NCT00381056 is a NA study of Adverse Maternal and Neonatal Outcomes that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 30,000 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (2038% higher). The trial reports 15 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00381056, a NA study of Adverse Maternal and Neonatal Outcomes, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 30,000 participants
- Enrollment target
- 15
- Study locations
Study Summary
A cluster-randomized controlled trial was conducted at 7 intervention and 8 control hospitals to evaluate the effect of teamwork training on the occurrence of adverse outcomes and processes of care in labor and delivery.
Conditions Studied
Interventions
- BEHAVIORAL Labor and Delivery Team Coordination Course
Study Locations (15)
California
- Naval Hospital Campe Pendleton - Oceanside
- Naval Medical Center San Diego - San Diego
Florida
- Baptist Health South Florda - Miami
- University of Miami - Miami
Maryland
- Johns Hopkins Hospital - Baltimore
- National Naval Medical Center Bethesda - Bethesda
Massachusetts
- Baystate Hospital - Springfield
- South Shore Hospital - Weymouth
Michigan
- University of Michigan - Ann Arbor
- Beaumont Hospital - Royal Oaks
Alabama
- University of Alabama - Birmingham
Hawaii
- Tripler Army Medical Center - Honolulu
Vermont
- University of Vermont - Burlington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30,000 participants |
| Start Date | 2000-07 |
| Est. Completion | 2004-03 |
| Phase | NA |
What the finished NCT00381056 record still lists
NCT00381056 is an interventional study that assigns participants to a tested intervention. Its 30,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (2038% higher).
The record links to 1 condition, with Adverse Maternal and Neonatal Outcomes appearing as the primary indexed condition, and to 1 intervention - of which Labor and Delivery Team Coordination Course is the first listed.
NCT00381056 lists 15 locations in 10 states (California, Florida, Maryland).
Frequently Asked Questions
What is clinical trial NCT00381056 about?
NCT00381056 is a clinical study titled "The Labor and Delivery Teamwork Intervention Trial". A cluster-randomized controlled trial was conducted at 7 intervention and 8 control hospitals to evaluate the effect of teamwork training on the occurrence of adverse outcomes and processes of care in labor and delivery.
What is the current status of trial NCT00381056?
This trial is currently completed. It is a NA study. The enrollment target is 30,000 participants. The study started on 2000-07. Estimated completion is 2004-03.
What conditions does trial NCT00381056 study?
This clinical trial studies the following conditions: Adverse Maternal and Neonatal Outcomes.
What interventions are being tested in trial NCT00381056?
The interventions under investigation include: Labor and Delivery Team Coordination Course (BEHAVIORAL).
Who is sponsoring clinical trial NCT00381056?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00381056 being conducted?
This trial has 15 study locations across Alabama, California, Florida, Hawaii, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00381056's enrollment target sits among peer trials
30,000 8th of 2000 higher than 1,992 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00684580 · 30,000 participants
Protocol For Collecting Data On Patients With Childhood Cancer
- NCT03053193 · 30,000 participants
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
- NCT03689595 · 30,000 participants
Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)
- NCT04834869 · 30,000 participants
COVID-19 Vaccines Safety Tracking (CoVaST)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia